Technical Data
13 May 2021

Catalent Oral Technology - Spray Drying Technology Data Sheet

PDF 281 kB

Catalent offers end-to-end spray drying solutions from early-phase development through to clinical supply, and scale-up to commercial finished dose forms. In 2019, Catalent expanded the capacity of its global spray drying operations through an agreement with Sanofi Active Ingredients Solutions (SAIS), an industrial platform of Sanofi, under which Sanofi provides Catalent with access to its spray-drying manufacturing capabilities at its Haverhill, U.K. facility. With subsequent additional investment into the site to expand its SDD capabilities, and alongside Catalent’s  global network of downstream dosage form manufacturing facilities, Catalent is well positioned to serve our global customers with end-to- end SDD solutions.

Content provided by our supplier

Catalent Pharma Solutions

  • US
  • 2015
    On CPhI since
  • 1
    Certificates
  • 5000+
    Employees

Other Content from Catalent Pharma Solutions